Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir   Bansal Dipika   Shafiq Nusrat   Pandhi Promila   Kumar Bhushan  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond diabetes: quo vadis?

By Pershadsingh Harrihar A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ and its Agonists in Hypertension and Atherosclerosis: Mechanisms and Clinical Implications

By Halabi Carmen M.   Sigmund Curt D.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 389-398

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Agonists for Management and Prevention of Vascular Disease in Patients with and without Diabetes Mellitus

By Ríos-Vázquez Ramón   Marzoa-Rivas Raquel   Gil-Ortega Ignacio   Juan Carlos Kaski  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 231-242

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

By Giaginis Costas   Margeli Alexandra   Theocharis Stamatios  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1561-1572

Informa Healthcare

Access to resources Recommend Favorite